Literature DB >> 6235836

Analysis of lymphocyte subsets in patients with aplastic anaemia.

N C Zoumbos, W O Ferris, S M Hsu, S Goodman, P Griffith, S O Sharrow, R K Humphries, A W Nienhuis, N Young.   

Abstract

Lymphocyte subsets have been measured in the blood of 28 patients with aplastic anaemia. The mean helper/inducer:suppressor/cytotoxic T lymphocyte ratio (1.24 +/- 0.74) was significantly decreased in the total population in comparison to mean ratios in a normal population (1.78 +/- 0.57) and in patients with other haematological diseases (1.82 +/- 0.92). A reversed ratio (less than or equal to 1) was present in a large proportion (53%) of aplastic patients, due both to an absolute deficiency of helper/inducer lymphocytes and an increase in suppressor/cytotoxic lymphocytes. Increased HLA-DR expression, evidence of lymphocyte activation, was present in seven of 12 patients evaluated and was confined to the suppressor/cytotoxic lymphocyte population. In the bone marrow, the percentage of lymphocytes was increased two-fold compared to normal bone marrow but the ratio of T cell subsets was not abnormal. Two of four patients evaluated after haematopoietic recovery following ATG treatment showed a return to normal of the T4/T8 ratio; in two others a low T4/T8 ratio persisted despite recovery. These results indicate that lymphocyte subset imbalance and lymphocyte activation are present in many patients with aplastic anaemia, either as a contributing factor or as a result of bone marrow failure.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235836     DOI: 10.1111/j.1365-2141.1984.tb06063.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  The function of lymphocytes in normal and suppressed hematopoiesis.

Authors:  N Zoumbos; P Gascon; N Young
Journal:  Blut       Date:  1984-01

Review 2.  Immune pathophysiology of aplastic anemia.

Authors:  Jaroslaw P Maciejewski; Antonio Risitano; Hoon Kook; Weihua Zeng; Guibin Chen; Neal S Young
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

3.  Hypoplastic acute leukemia: description of eight cases and search for hematopoietic inhibiting activity.

Authors:  R de Bock; M de Jonge; M Korthout; E Wouters; D van Bockstaele; M van der Planken; M Peetermans
Journal:  Ann Hematol       Date:  1992-12       Impact factor: 3.673

4.  Identification of activated T cells and the suppressor/inducer subset in patients suffering from severe aplastic anemia.

Authors:  U Köller; W Hinterberger; L Gschwandtler; R Grümayer; O Majdic; W Knapp
Journal:  Blut       Date:  1989-01

5.  Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.

Authors:  D Binder; M F van den Broek; D Kägi; H Bluethmann; J Fehr; H Hengartner; R M Zinkernagel
Journal:  J Exp Med       Date:  1998-06-01       Impact factor: 14.307

6.  Increased bone marrow (BM) plasma level of soluble CD30 and correlations with BM plasma level of interferon (IFN)-γ, CD4/CD8 T-cell ratio and disease severity in aplastic anemia.

Authors:  Qingqing Wu; Jizhou Zhang; Jun Shi; Meili Ge; Xingxin Li; Yingqi Shao; Jianfeng Yao; Yizhou Zheng
Journal:  PLoS One       Date:  2014-11-10       Impact factor: 3.240

Review 7.  Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress.

Authors:  Allison N Seyfried; Jackson M Maloney; Katherine C MacNamara
Journal:  Front Immunol       Date:  2020-07-23       Impact factor: 7.561

8.  Hematopoietic stem cell loss and hematopoietic failure in severe aplastic anemia is driven by macrophages and aberrant podoplanin expression.

Authors:  Amanda McCabe; Julianne N P Smith; Angelica Costello; Jackson Maloney; Divya Katikaneni; Katherine C MacNamara
Journal:  Haematologica       Date:  2018-05-17       Impact factor: 9.941

Review 9.  Viruses, virulence and pathogenicity.

Authors:  J Hibbs; N S Young
Journal:  Baillieres Clin Haematol       Date:  1995-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.